Abstract:Background & Objectives: Acute Respiratory Distress Syndrome (ARDS) is common and frequently fatal condition characterized by overwhelming inflammation. Resolution of inflammation is an active biological process regulated by endogenous specialized lipid mediators including resolvins. Fibroblasts, farfrom being matrix-producing reparative cells, could exhibit specific function in resolution. Cyclooxygenase-2(COX-2) is inducible by inflammatory stimuli and was reported to drive inflammation by peaking in onset of inflammation as well as resolve inflammation with maximal expression in resolution phase. Interestingly, Resolvin D1 (RvD1) plays a biphasic role on both peaks of COX-2 to exert its anti-inflammation and pro-resolution actions. In this study, we aim to work out the underlying mechanism for RvD1 promoting COX-2 expression in regulating inflammatory resolution in fibroblasts. Materials & Methods: Pulmonary fibroblasts were isolated from Sprague-Dawley rats and cultured for 48 h with 1μg/ml LPS (lipopolysaccharide) and/or 100nM RvD1.The expression of COX-2,nuclear NF-κB protein (P65,P50,RelB) were measured by western blot, the activation of NF-kB was assessed by Electrophoretic mobility-gel shift assay (EMSA) and supershift. Results: After incubated with LPS for 48h, fibroblasts were treated with inhibitors of P38MARK (SB203580), JNK (SP600125), NF-κB (MG-132) pathways involved in regulation COX-2 expression, only NF-κB inhibitor inhibited COX-2 expression compared to LPS group (P<0.01,n=6). NF-κB was activated in fibroblasts with LPS challenged and only P50/P50 homodimer was activated after LPS stimulated 48h with the assessment of EMSA, supershift and nuclear protein western blot, whereas there was no significant change in P65 and RelB subunits between control and LPS group.RvD1 further promoted the P50 nuclear translocation and DNA binding activation with LPS incubated for 48h(P<0.05, n=8). Moreover, the RvD1 effects on COX-2 resolving expression in fibroblasts was abrogated when P50 knockout and the COX-2 level in P50-/- fibroblasts was much lower than that in wildtype ones after LPS stimulated 48h (P<0.001, n=4). Conclusion: RvD1-derived promotion of COX-2 expression is beneficial for complete resolution of inflammation, which is partly through activated NF-κB P50/P50 homodimer.As timely inflammatory resolution is essential for host homeostasis, RvD1 might have therapeutic potential in the management of ARDS. References: 1. Wu D, Zheng S, Li W, Yang L, Liu Y, Zheng X, Yang Y, Yang L, Wang Q, Smith FG et al: Novel biphasic role of resolvin D1 on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts is partly through PI3K/AKT and ERK2 pathways. Mediators of inflammation 2013, 2013:964012. Disclosure of Interest: None declared

Anti-inflammatory actions of aspirin-triggered resolvin D1 (AT-RvD1) in bronchial epithelial cells stimulated by cigarette smoke extract

Protective Actions of Aspirin-Triggered (17R) Resolvin D1 and Its Analogue, 17R-Hydroxy-19-para-fluorophenoxy-resolvin D1 Methyl Ester, in C5a-Dependent IgG Immune Complex–Induced Inflammation and Lung Injury

Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages

Modulation of the endogenous Annexin A1 in a cigarette smoke cessation model: Potential therapeutic target in reversing the damage caused by smoking?

Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model

WNT/β-catenin Signaling Regulates Cigarette Smoke-Induced Airway Inflammation Via the PPARδ/p38 Pathway

CRTH2 Antagonist, CT‑133, Effectively Alleviates Cigarette Smoke-Induced Acute Lung Injury

Aurintricarboxylic acid mitigates cigarette smoke extract induced oxidative stress and pulmonary inflammation via inhibition of NF-ҡB/p65 signaling

A new antioxidant formulation reduces the apoptotic and damaging effect of cigarette smoke extract on human bronchial epithelial cells

Aspirin-Triggered Resolvin D1 (AT-RvD1) Protects Mouse Skin against UVB-Induced Inflammation and Oxidative Stress

Resolvin D1 Improves the Resolution of Inflammation via Activating NF-κB p50/p50-Mediated Cyclooxygenase-2 Expression in Acute Respiratory Distress Syndrome

Roxadustat Alleviates Cigarette-Induced COPD via the VEGF-A Pathway

Exposure to Cigarette Smoke Downregulatesβ2-Adrenergic Receptor Expression and Upregulates Inflammation in Alveolar Macrophages

Rosmarinic acid inhibits nicotine‐induced C‐reactive protein generation by inhibiting NLRP3 inflammasome activation in smooth muscle cells

Smoking-induced aggravation of experimental arthritis is dependent of aryl hydrocarbon receptor activation in Th17 cells

Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma

Epoxyeicosatrienoic Acids Attenuate Cigarette Smoke Extract-Induced Interleukin-8 Production in Bronchial Epithelial Cells

A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice

Endoplasmic Reticulum Stress Induces HRD1 to Protect Alveolar Type II Epithelial Cells from Apoptosis Induced by Cigarette Smoke Extract

Abstract PR099: Resolvin D1 Improves the Resolution of Inflammation Via Activation P50/P50-Mediated Cyclooxygenase-2 Expression in Fibroblasts.